Biogen Inc. (BIIB)

Balance Sheet: Liabilities and Stockholders’ Equity

Difficulty: Beginner

The balance sheet provides creditors, investors, and analysts with information on company’s resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company’s assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Biogen Inc., consolidated balance sheet: liabilities and stockholders’ equity

US$ in thousands

		Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Current portion of notes payable
	Taxes payable
	Accounts payable
	Revenue-related reserves for discounts and allowances
	Current portion of contingent consideration obligations
	Employee compensation and benefits
	Royalties and licensing fees
	Construction in progress
	Collaboration expenses
	Accrued TECFIDERA litigation settlement charges
	Other
	Accrued expenses and other
	Current liabilities
	Notes payable, excluding current portion
	Deferred tax liability
	Other long-term liabilities
	Non-current liabilities
	Total liabilities
	Preferred stock, par value $0.001 per share
	Common stock, par value $0.0005 per share
	Additional paid-in capital
	Accumulated other comprehensive loss
	Retained earnings
	Treasury stock, at cost
	Total Biogen Inc. shareholders’ equity
	Noncontrolling interests
	Total equity
	Total liabilities and equity

Based on: 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03), 10-K (filing date: 2015-02-04).

Balance sheet item	Description	The company
Current liabilities	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.	Biogen Inc.’s current liabilities declined from 2016 to 2017 and from 2017 to 2018.
Non-current liabilities	Amount of obligation due after one year or beyond the normal operating cycle, if longer.	Biogen Inc.’s non-current liabilities increased from 2016 to 2017 and from 2017 to 2018.
Total liabilities	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.	Biogen Inc.’s total liabilities increased from 2016 to 2017 and from 2017 to 2018.
Total Biogen Inc. shareholders’ equity	Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.	Biogen Inc.’s total Biogen Inc. shareholders’ equity increased from 2016 to 2017 and from 2017 to 2018.

	Biogen Inc.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality